Skip to main content
Fig. 2 | Annals of Intensive Care

Fig. 2

From: Mortality, incidence, and microbiological documentation of ventilated acquired pneumonia (VAP) in critically ill patients with COVID-19 or influenza

Fig. 2

Microbiological characteristics of VAP, early and late VAP for patients with COVID or influenza. GP = Gram-positive; MRSA: Methicillin resistant Staphylococcus aureus, Enterococ: Enterococcus, CNS coagulase negative Staphylococcus, GN gram negative, Enterobact Enterobacteriaceae, R to 3rdGC Resistant to third generation cephalosporin, ESBL Extended spectrum beta lactamase, AmpC Derepressed cephalosporinase, R to ticar, cefta or carba: Resistant to ticarcillin, ceftazidime or carbapenems; > 1 bact: More than one bacteria

Back to article page